CellsIA is transforming diagnostic pathology through responsible, AI-powered digital solutions.
Our platform, NucleiQ, empowers pathologists, hospitals, and laboratories to improve diagnostic precision, reduce turnaround times, and optimize workflow efficiency.
We develop tailored AI algorithms for key clinical areas such as breast, gastrointestinal, gynecological, and urological pathology, ensuring seamless integration with existing hospital information systems.
With a strong commitment to patient-centered care, interoperability, and clinical safety, CellsIA is leading the shift toward high-value digital pathology.
📍 Based in Madrid, Spain
🌍 Operating internationally
🔬 Experts in medical AI, digital health, and computational pathology
Company Details
- Employees
- 19
- Founded
- -
- Address
- Calle De Albasanz, 76, 4ª Planta,spain
- Industry
- Technology, Information And Internet
- Website
- http://cells-ia.com
- HQ
- Madrid, Community of Madrid
Cells Ia Questions
Cells Ia's website is http://cells-ia.com
Cells Ia's LinkedIn profile is https://es.linkedin.com/company/cellsia
Cells Ia has
19 employees.
View email and phone details for 19
employees at Cells Ia.
Cells Ia's industry is
Technology, Information and Internet
Cells Ia's top competitors are
Adastra Capital,
Kunsen,
Rovi Pharmaceutical Company,
Cofares,
Cella Medical Solutions,
Auren Personas - Selección & Executive Search,
Santander,
Health Time,
Gsk,
Konexio Biotech.
Cells Ia's categories are Technology, Information and Internet
Cells Ia's founding year is 2020
